Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story"

Journal of Medicinal Chemistry

Volumn 58, Issue 12, 2015, Pages 4874-4882

  Bisacchi, Gregory S ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; NALIDIXIC ACID; QUINOLONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REACTION ANALYSIS; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; HISTORY; HUMAN; PROCEDURES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG DISCOVERY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NALIDIXIC ACID; QUINOLONES;

EID: 84933074046     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm501881c     Document Type: Review

References (79)

1. Mitscher, L. A. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents Chem. Rev. 2005, 105, 559-592
2. Albrecht, R. Development of antibacterial agents of the nalidixic acid type Prog. Drug Res. 1977, 21, 9-104
3. Lesher, G. Y. Nalidixic Acid and Other Quinolone Carboxylic Acids. In Kirk-Othmer Encyclopedia of Chemical Technology, 3 rd ed.; Grayson, M.; Eckroth, D., Eds.; John Wiley: New York, 1978; Vol. 2, pp 782-789.
4. Wentland, M. P.; Cornett, J. B. Quinolone Antibacterial Agents. In Annual Reports in Medicinal Chemistry; Bailey, D. M., Ed.; Academic Press: San Diego, CA, 1985; Vol. 20, pp 145-154.
5. Fernandes, P. B.; Chu, D. T. W. Quinolones. In Annual Reports in Medicinal Chemistry; Bailey, D. M., Ed.; Academic Press: San Diego, CA, 1987; Vol. 22, pp 117-126.
6. Reuman, M.; Lesher, G. Y. Antibacterial Agents, Synthetic Quinolones. In Kirk-Othmer Encyclopedia of Chemical Technology, 4 th ed.; Kroschwitz, J. I., Ed.; John Wiley: New York, 1992; Vol. 2, pp 854-869.
7. Chu, D. T. W.; Shen, L. L. Quinolones: Synthetic Antibacterial Agents. In Fifty Years of Antimicrobials: Past Perspectives and Future Trends, 53rd Symposium of the Society for General Microbiology; Cambridge University Press: Cambridge, U.K., 1995; pp 111-137.
8. Radl, S. From chloroquine to antineoplastic drugs? The story of antibacterial quinolones Arch. Pharm. 1996, 329, 115-119
9. Dax, S. L. Quinolone Antibacterials. In Antibacterial Chemotherapeutic Agents; Dax, S. L., Ed.; Blackie Academic & Professional: London, 1997; pp 298-345.
10. Andriole, V. T. The Quinolones, 3 rd ed.; Academic Press: London, 2000.
11. Scholar, E. M.; Pratt, W. B. The Fluoroquinolones. In The Antimicrobial Drugs, 2 nd ed.; Oxford University Press: Oxford, U.K., 2000; pp 257-279.
12. Domagala, J. M.; Hagen, S. E. Structure-Activity Relationships of the Quinolone Antibacterials in the New Millennium: Some Things Change and Some Do Not. In Quinolone Antimicrobial Agents, 3 rd ed.; Hooper, D. C.; Rubenstein, E., Eds.; ASM Press: Washington, DC, 2003; pp 3-18.
13. Sheehan, G.; Chew, N. S. Y. The History of Quinolones. In Fluoroquinolone Antibiotics; Ronald, A. R.; Low, D. E., Eds.; Birkhaeuser Verlag: Basel, Switzerland, 2003; pp 1-10.
14. Bambeke, F. V.; Michot, J. -.; Eldere, J. V.; Tulkens, P. M. Quinolones in 2005: an update Clin. Microbiol. Infect. 2005, 11, 256-280
15. Andriole, V. T. The quinolones: past, present, and future Clin. Infect. Dis. 2005, 41 (Suppl. 2) S113-S119
16. Wagman, A. S.; Wentland, M. P. Quinolone Antibacterial Agents. In Comprehensive Medicinal Chemistry II; Taylor, J. B.; Triggle, D., Eds.; Elsevier: Amsterdam, The Netherlands, 2007; pp 567-596.
17. Wiles, J. A.; Bradbury, B. J.; Pucci, M. J. New quinolone antibiotics: a survey of the literature from 2005 to 2010 Expert Opin. Ther. Pat. 2010, 20, 1295-1319
18. Eliopoulos, G. M. Activity of newer fluoroquinolones in vitro against gram-positive bacteria Drugs 1999, 58 (Suppl. 2) 23-28
19. Butler, M. S.; Blaskovich, M. A.; Cooper, M. A. Antibiotics in the clinical pipeline in 2013 J. Antibiot. (Tokyo) 2013, 66, 571-591
20. de Souza Mendes, C.; de Souza Antunes, A. Pipeline of known chemical classes of antibiotics Antibiotics 2013, 2, 500-534
21. Qin, X.; Huang, H. Review of nemonoxacin with special focus on clinical development Drug Des. Dev. Ther. 2014, 8, 765-774
22. Odagiri, T.; Inagaki, H.; Sugimoto, Y.; Nagamochi, M.; Miyauchi, R. N.; Kuroyanagi, J.; Kitamura, T.; Komoriya, S.; Takahashi, H. Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens J. Med. Chem. 2013, 56, 1974-1983
23. Douros, A.; Grabowski, K.; Stahlmann, R. Safety issues and drug-drug interactions with commonly used quinolones Expert Opin. Drug Metab. Toxicol. 2015, 11, 25-39
24. Sousa, J.; Alves, G.; Fortuna, A.; Falcao, A. Third and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profiles Curr. Drug Saf. 2014, 9, 89-105
25. Schuster, D.; Laggner, C.; Langer, T. Why drugs fail-a study on side effects in new chemical entities Curr. Pharm. Des. 2005, 11, 3545-3559
26. Linder, J. A.; Huang, E. S.; Steinman, M. A.; Gonzales, R.; Stafford, R. S. Fluoroquinolone prescribing in the United States: 1995 to 2002 Am. J. Med. 2005, 118, 259-268
27. Greenwood, D. Antimicrobial Drugs. Chronicle of a Twentieth Century Medical Triumph; Oxford University Press: Oxford, U.K., 2008; pp 209-268.
28. Lesher, G. Y.; Froelich, E. J.; Gurett, M. D.; Baily, J. H.; Brundage, R. P. 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents J. Med. Pharm. Chem. 1962, 91, 1063-1065
29. Lesher, G. Y. Nalidixic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid. A new antibacterial agent Int. Congr. Chemother., Proc. 1964, 2, 1367-1369
30. Lesher, G. Y. Presented at the International Symposium on Quinolone Antibiotics, Chicago, IL, Sept 24-26, 1986.
31. Wentland, M. P. In Memorium: George Y. Lesher, Ph.D. 22 February 1926-17 March 1990. In Quinolone Antimicrobial Agents, 2 nd ed.; Hooper, D. C.; Wolfson, J. S., Eds.; American Society for Microbiology: Washington, DC, 1993; pp xiii-xiv.
32. Petranyi, G.; Ryder, N. S.; Stuetz, A. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase Science 1984, 224, 1239-1241
33. Stuetz, A. Synthesis and structure-activity correlations within allylamine antimycotics Ann. N.Y. Acad. Sci. 1988, 544, 46-62
34. Lesher, G. Y.; Gruett, M. D. 3-X-4-Oxo-1,8-naphthyridines et Leur Preparation. BE612258, July 3, 1962.
35. Barton, N.; Crowther, A. F.; Hepworth, W.; Richardson, N. D.; Driver, G. W. New Quinolones and Therapeutic Compositions Containing Them. GB830832, March 23, 1960.
36. Hepworth, W.; Richardson, D. N. Substituted Nitro-quinolones. GB831885, April 6, 1960.
37. Crowther, A. F.; Hepworth, W.; Moreley, J. S. Pharmaceutical compositions comprising quinolone derivatives. GB835474, May 18, 1960.
38. Hepworth, W. Manufacture of 1-Methyl-6-nitro-4-quinolone-3-carboxylic Acid. GB820295, Sep 16, 1959.
39. Hepworth, W. Manufacture of 1-Methyl-6-nitro-4-quinolone-3-carboxylic Acid. GB822586, Oct 28, 1959.
40. Crow, W. D.; Price, J. R. Alkaloids of the Australian Rutaceae: Melicope fareana. V. The structure of the alkaloids Aust. J. Sci. Res., Ser. B 1949, 282-306
41. Drummond, L. J.; Lahey, F. N. Alkaloids of the Australian Rutaceae: Acronychia baueri. III. The structure of acronycine Aust. J. Sci. Res., Ser. B 1949, 631-637
42. Price, J. R. Alkaloids of the Australian Rutaceae: Melicope fareana. IV. Some reactions of 1-methyl-4-quinolone-3-carboxylic acid, a degradation product of the alkaloids Aust. J. Sci. Res., Ser. B 1949, 272-281
43. Lesher, G. Y. 1-Alkyl-1,4-dihydro-4-oxo-3-quinoline-carboxylic Acids and Esters; US3472850, Oct 14, 1969.
44. Gould, R. G.; Jacobs, W. A. Synthesis of certain substituted quinolines and 5,6-benzoquinolines J. Am. Chem. Soc. 1939, 61, 2890-2895
45. Price, C. C.; Roberts, R. M. The synthesis of 4-hydroxyquinolines; through ethoxymethylene malonic ester J. Am. Chem. Soc. 1946, 68, 1204-1208
46. Surrey, A. R.; Hammer, H. F. Some 7-substituted 4-aminoquinoline derivatives J. Am. Chem. Soc. 1946, 68, 113-116
47. Surrey, A. R.; Cutler, R. A. The preparation of 3-halo-4-dialkylaminoalkylamino-quinoline derivatives J. Am. Chem. Soc. 1946, 68, 2570-2574
48. Price, C. C.; Leonard, N. J.; Reitsma, R. H. Synthesis of 4-hydroxyquinolines; a direct synthesis from beta-anilinoacrylates J. Am. Chem. Soc. 1946, 68, 1256-1259
49. Kenyon, R. L.; Wiesner, J. A.; Kwartler, C. E. Chloroquine manufacture Ind. Eng. Chem. 1949, 41, 654-662
50. Raychaudhuri, A.; Basu, U. P. Side products in the preparation of ethyl 7-chloro-4-hydroxyquinoline-3-carboxylate from diethyl ethoxymethylenemalonate and m-chloroaniline J. Indian Chem. Soc. 1970, 47, 25-32
51. Raychaudhuri, A. Side products in the preparation of ethyl 7-chloro-4-hydroxyquinoline-3-carboxylate-an intermediate for chloroquine Curr. Sci. 1967, 36, 459
52. Kaminsky, D.; Meltzer, R. I. Medicament a Base de Derives dAcide Carboxylique. FR M4148, 1967.
53. Kaminsky, D.; Meltzer, R. I. 1-Methyl-3-carboxy-6,7-dimethoxy-4-(1 H)-quinolone Proteus Infection Treatment. US 3,172,811, 1965.
54. Podmore, W. D.; Bayley, L. New Quinolone Derivatives and Compositions Comprising Them. BP1070333, 1967.
55. Wentland, M. P. Structure-activity relationships of fluoroquinolones Infect. Dis. Ther. 1990, 5 (The New Generation of Quinolones) 1-43
56. Albrecht, R. Investigations about the antibacterial activity of quinolonecarboxylic acids. III. Methyl 1-ethyl-4-quinolone-3-carboxylates and some 3-substituted quinolones Chim. Ther. 1973, Janvier-Fevrier) 45-48
57. Markees, D. G.; Schwab, L. S.; Vegotsky, A. Synthesis and antibacterial activity of some substituted 4-quinolone-3-carboxylic acids J. Med. Chem. 1974, 17, 137-139
58. Agui, H.; Komatsu, T.; Nakagome, T. Studies on quinoline derivatives and related compounds. II. Synthesis of 5-substituted 1-ethyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid (1) J. Heterocycl. Chem. 1975, 12, 557-563
59. Barreau, M.; Roquet, F. Les quinolones antibacteriennes: de lacide nalidixique a la pefloxacine Actual. Chem. 1987, Juin-Juillet) 197-201
60. Kojima, T.; Mitsuhashi, S. History of quinolone antibacterials Prog. Drug Res. 1992, 38, 11-17
61. Petersen, U. Quinolone Antibiotics: The Development of Moxifloxacin. In Analogue-Based Drug Discovery; Fisher, J.; Ganellin, C. R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2006; pp 315-370.
62. Landquist, J. K. Synthetic antimalarials. Part XLVI. Some 4-dialkyl-aminoalkylaminoquinoline derivatives J. Chem. Soc. 1951, 1038-1048
63. Nichols, W. W.; Franklin, T. J.; Gravestock, M. B.; Bring, B. G.; Ekstrom, B.; Balganesh, T. S.; Kumar, S. A.; Doig, P.; Noonan, B. History of anti-infective research at AstraZeneca. Part I: ICI/Zeneca/AstraZeneca SIM News 2009, 218-237
64. Landquist, J. K. Quaternary salts of pyrido(1,2- a)pyrimidines J. Chem. Soc., Perkin Trans. 1 1971, 15, 2735-2738
65. Artico, M.; Mai, A.; Sbardella, G.; Massa, S.; Musiu, C.; Lostia, S.; Demontis, F.; La Colla, P. Nitroquinolones with broad-spectrum antimycobacterial activity in vitro Bioorg. Med. Chem. Lett. 1999, 9, 1651-1656
66. Koga, H.; Itoh, A.; Murayama, S.; Suzue, S.; Irikura, T. Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids J. Med. Chem. 1980, 23, 1358-1363
67. Cecchetti, V.; Fravolini, A.; Lorenzini, M. C.; Tabarrini, O.; Terni, P.; Xin, T. Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones J. Med. Chem. 1996, 39, 436-445
68. Cecchetti, V.; Clementi, S.; Cruciani, G.; Fravolini, A.; Pagella, P. G.; Savino, A.; Tabarrini, O. 6-Aminoquinolones: a new class of quinolone antibacterials? J. Med. Chem. 1995, 38, 973-982
69. Domagala, J. M.; Hanna, L. D.; Heifetz, C. L.; Hutt, M. P.; Mich, T. F.; Sanchez, J. P.; Solomon, M. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay J. Med. Chem. 1986, 29, 394-404
70. Mahmood, F.; Mahmood, N. H. Antibacterial action of quinolones on Escherichia coli. IIa. Conditions required for lethality: effect of anaerobiosis, inoculum size and media composition Zentralbl. Bakteriol. A 1980, 247, 221-228
71. Mahmood, F.; Mahmood, N. H.; Holms, W. H. Antibacterial action of quinolones on Escherichia coli. I. Structure/activity relationship Zentralbl. Bakteriol. A 1980, 246, 329-335
72. Hepworth, W.; Morley, J. S.; Stacy, G. J. Nitroquinolones. GB846611, Aug 31, 1960.
73. Birtwell, S.; Hepworth, W. Quinoline Derivatives; GB874980, Aug 16, 1961.
74. McOsker, C. C.; Fitzpatrick, P. M. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens J. Antimicrob. Chemother. 1994, 33 (Suppl. A) 23-30
75. Edwards, D. I. Nitroimidazole drugs-action and resistance mechanisms. I. Mechanisms of action J. Antimicrob. Chemother. 1993, 31, 9-20
76. Gurumurthy, M.; Mukherjee, T.; Dowd, C. S.; Singh, R.; Niyomrattanakit, P.; Tay, J. A.; Nayyar, A.; Lee, Y. S.; Cherian, J.; Boshoff, H. I.; Dick, T.; Barry, C. E., III; Manjunatha, U. H. Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles FEBS J. 2012, 279, 113-125
77. Hartkoorn, R. C.; Ryabova, O. B.; Chiarelli, L. R.; Riccardi, G.; Makarov, V.; Cole, S. T. Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis Antimicrob. Agents Chemother. 2014, 58, 2944-2947
78. Tiwari, R.; Moraski, G. C.; Krchnak, V.; Miller, P. A.; Colon-Martinez, M.; Herrero, E.; Oliver, A. G.; Miller, M. J. Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents J. Am. Chem. Soc. 2013, 135, 3539-3549
79. Tani, J.; Mushika, Y.; Yamaguchi, T. Studies on biologically active halogenated compounds. III. Synthesis and antibacterial activity of 7-fluoromethyl-1,8-naphthyridine and quinoline derivatives Chem. Pharm. Bull. (Tokyo) 1982, 30, 3517-3529